BioSpace News Archive

Shanghai Wision AI Co., Ltd, a leader in developing computer-aided diagnostic algorithms and systems to improve the accuracy and effectiveness of diagnostic imaging, today announced results of a study validating a novel machine-learning algorithm that improves detection of adenomatous polyps during colonoscopy.

Today, the U.S. Food and Drug Administration and the Department of Defense’s (DoD) Office of Health Affairs signed a Memorandum of Understanding regarding medical product development and assessment.

CHF Solutions, Inc. (Nasdaq: CHFS) announced today that it has entered into a collaboration agreement with Daxor Corporation (NYSE:DXR) to explore potential synergies between the company’s Aquadex FlexFlow® System and Daxor’s BVA-100 Blood Volume Analyzer.

FUJIFILM Diosynth Biotechnologies (FDB) today announced that its contribution with the Centre for Process Innovation (CPI) to the collaboration project entitled ‘AMECRYS- Revolutionizing Downstream Processing of Monoclonal Antibodies by Continuous Template-Assisted Membrane Crystallisation’ has hit an important milestone with the successful technology transfer of the expression and purification of model mAbs from FDB to CPI.

Coalition pushes forward on improving science-based food safety program during FDA investigation

CRF Health, a CRF Bracket company, the leading provider of patient-centered eSource technology solutions for the life sciences industry, today announced the awarding of two new contracts by top-20 pharma companies, which will see the company’s innovative eCOA solutions used to capture patient-reported outcomes in 15 global dermatology trials.

ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the United States and Europe, today announced that two abstracts containing new data on ASLAN003 have been accepted for poster presentation at the upcoming 60th American Society of Hematology (ASH) Annual Meeting in San Diego, US on 1 – 4 December 2018.

Today, the U.S. Food and Drug Administration permitted marketing of two devices that provide real-time location of parathyroid tissue during surgical procedures such as thyroidectomy (surgery to remove all or part of the thyroid) and parathyroidectomy (surgery to remove one or more parathyroid glands).

Akebia Therapeutics, Inc. granted four newly-hired employees options to purchase an aggregate of 25,400 shares of Akebia’s common stock on October 31, 2018, as inducements material to each such employee’s entering into employment with Akebia.

Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, announced today that it will report its financial results for the three and nine months ended September 30, 2018 in a press release that will be issued pre-market on Thursday November 8, 2018.